• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Clearmind Medicine Inc (NQ: CMND )

    1.390 -0.070 (-4.79%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Clearmind Medicine Inc

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
    From SciSparc Ltd
    Via GlobeNewswire
    Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
    Via Benzinga
    Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
    Via Benzinga
    Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
    New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian... 
    Via Benzinga
    Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. 
    Via Benzinga
    Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
    Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares this morning! 
    Via InvestorPlace
    Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. 
    Via Benzinga
    PsychedelicNewsBreaks – Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) (FSE: CWY0) Selects Aegis Capital Corp. as Sole Bookrunner for $2.4M Private Placement
    Via Investor Brand Network
    Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private Placement
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Aegis Capital Corp. Acted as Sole Bookrunner on a $2.4 Million Registered Direct and Private Placement for Clearmind Medicine Inc. (NASDAQ: CMND)
    Via ACCESSWIRE
    Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
    Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.  
    Via Benzinga
    Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
    Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD 
    Via Benzinga
    Crude Oil Moves Higher; Clearmind Medicine Shares Plummet
    U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 20 points on Thursday. The Dow traded down 0.05% to 37,675 while the NASDAQ fell 0.05% to 14,962.80.... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged... 
    Via Benzinga
    Dow Dips Over 200 Points; First Financial Northwest Shares Spike Higher
    U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 200 points on Thursday. The Dow traded down 0.56% to 37,483.91 while the NASDAQ fell 0.86% to 14,840.28. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Clearmind Medicine (CMND) Shares Are Nosediving
    Clearmind Medicine Inc (NASDAQ: CMND) shares are trading lower by 45% to $1.61 Thursday morning after the company finalized agreements with institutional investors for a 
    Via Benzinga
    US Stocks Higher; Inflation Rate Increases To 3.4% In December
    U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.07% to 37,723.53 while the NASDAQ rose... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    CRM Stock Alert: Baird Boosts Salesforce With New Upgrade
    Salesforce stock is gaining on Thursday after shares of CRM got an upgrade and increased price target from Baird analysts. 
    Via InvestorPlace
    Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    Goldman Sachs Is Cooling Off on LYFT Stock
    Lyft stock is on the move Thursday after the ridesharing company's shares were hit with a downgrade from Goldman Sachs. 
    Via InvestorPlace
    Why Is Clearmind Medicine (CMND) Stock Down 24% Today?
    Clearmind Medicine stock is falling on Thursday after shares of CMND underwent a major rally yesterday on a meeting with regulators. 
    Via InvestorPlace
    Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
    Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted weaker-than-expected results for its second quarter. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning! 
    Via InvestorPlace
    Crude Oil Falls 1%; Amarin Shares Spike Higher
    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results. 
    Via Benzinga
    Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week
    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.